Breadcrumb Home Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPending Sort Study Number AscStudy Number Desc Submit Search Showing 13 studies. P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Therapeutics Study Status Closed to Follow Up 1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed 1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival) DAIDS Number 10779 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed P1069: GPO-VIR Z30 DAIDS Number 10620 Research Area Other Study Status Concluded P1065: Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth (Versions 1.0 - 3.0) and Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth (Version 4.0) DAIDS Number 10396 Research Area Other Study Status Concluded P1056: GPO-VIR PK Study DAIDS Number 10139 Research Area Other Study Status Concluded P1053: Evaluation PI-Containing vs. Non-PI-Containing Salvage Regimens. DAIDS Number 10131 Research Area Other Study Status Concluded P1047: Safety And Immunogenicity Of QHPV In HIV+ Children 7-11 Years Of Age. DAIDS Number 10163 Research Area Other Study Status Concluded P1041: Efficacy of Isoniazid to prevent TB DAIDS Number 10047 Research Area Other Study Status Concluded P1036A: Directly Observed Therapy in HIV-Infected Adolescents. DAIDS Number 10193 Research Area Other Study Status Concluded Pagination Current page 1 Page 2 Next page Next
P1084s: Maternal Infant TDF Toxicity Safety DAIDS Number 10790 Research Area Therapeutics Study Status Closed to Follow Up
1077BF: PROMISE 1077BF DAIDS Number 10777 Research Area Prevention Study Status Participants Off Study and Primary Analysis Completed
1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival) DAIDS Number 10779 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed
P1065: Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth (Versions 1.0 - 3.0) and Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth (Version 4.0) DAIDS Number 10396 Research Area Other Study Status Concluded
P1053: Evaluation PI-Containing vs. Non-PI-Containing Salvage Regimens. DAIDS Number 10131 Research Area Other Study Status Concluded
P1047: Safety And Immunogenicity Of QHPV In HIV+ Children 7-11 Years Of Age. DAIDS Number 10163 Research Area Other Study Status Concluded
P1041: Efficacy of Isoniazid to prevent TB DAIDS Number 10047 Research Area Other Study Status Concluded
P1036A: Directly Observed Therapy in HIV-Infected Adolescents. DAIDS Number 10193 Research Area Other Study Status Concluded
